In Vivo Imaging: Advancing Preclinical and Translational Science in Molecular and Orthopedic Research at UCLA
On Demand Webinar
Preclinical imaging enables the measurement and assessment of biological processes in vivo utilizing technologies such as bioluminescence, fluorescence and PET platforms to assay cells, tissues, and living organisms. PerkinElmer’s suite of optical imaging systems and PET scanners set the industry standard for sensitivity, quantitative accuracy, and data reproducibility. This enables premier research institutions such as UCLA the opportunity to advance preclinical and translational science while fostering collaboration among imaging laboratories both internally and externally.
In this institutional highlight webinar, our presenters shared insights on how a successful imaging program at UCLA has been instrumental in generating novel models of disease and conducting cutting edge research.
During this webinar, the presenters:
- Highlighted preclinical imaging technologies and their application in biomedical and translational studies at the Crump Institute for Molecular Imaging at UCLA
- Presented collaborative work between groups at UCLA, USD and Johns Hopkins highlighting the development of a preclinical model of posterior-approach spinal surgery
- Discussed results employing this model demonstrating how spine implant infections can be monitored non-invasively and longitudinally in real-time using in vivo imaging
| Presenters | |
|
Jason T. Lee, Ph.D. Director, Preclinical Imaging Technology Center, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA |
|
Nicholas Bernthal, M.D.
Chief, Div. of Musculoskeletal Oncology Director, UCLA Global Orthopaedic Initiative, Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA |
Watch Now
Original Broadcast Date:
1 December 2016
Duration: 01:05:51